1. Home
  2. AU vs BIO Comparison

AU vs BIO Comparison

Compare AU & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AngloGold Ashanti PLC

AU

AngloGold Ashanti PLC

HOLD

Current Price

$91.11

Market Cap

43.1B

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$319.39

Market Cap

8.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AU
BIO
Founded
1944
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Laboratory Analytical Instruments
Sector
Basic Materials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
43.1B
8.7B
IPO Year
1972
N/A

Fundamental Metrics

Financial Performance
Metric
AU
BIO
Price
$91.11
$319.39
Analyst Decision
Buy
Strong Buy
Analyst Count
6
4
Target Price
$82.67
$358.50
AVG Volume (30 Days)
2.3M
169.4K
Earning Date
02-18-2026
02-12-2026
Dividend Yield
2.11%
N/A
EPS Growth
237.48
N/A
EPS
4.53
N/A
Revenue
$8,575,000,000.00
$2,557,500,000.00
Revenue This Year
$71.69
$1.62
Revenue Next Year
$14.39
$2.26
P/E Ratio
$20.48
N/A
Revenue Growth
61.82
N/A
52 Week Low
$24.24
$211.43
52 Week High
$93.85
$373.69

Technical Indicators

Market Signals
Indicator
AU
BIO
Relative Strength Index (RSI) 59.27 57.57
Support Level $82.94 $300.26
Resistance Level $93.85 $328.25
Average True Range (ATR) 2.73 7.26
MACD 0.19 2.52
Stochastic Oscillator 74.06 71.96

Price Performance

Historical Comparison
AU
BIO

About AU AngloGold Ashanti PLC

Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: